It has furthermore been documented that the supplementation of α-linolenic acid at a specific concentration exhibits a markedly greater impact on the amelioration of cardiovascular disease, and it impedes the proliferation and spread of osteosarcoma cells by suppressing the expression of fatty acid synthase (FASN). Here, FASN is linked to osteosarcoma.